The Effect of 1 Year of Romosozumab on the Incidence of Clinical Vertebral Fractures in Postmenopausal Women With Osteoporosis: Results From the FRAME Study
ABSTRACT Radiographic vertebral fractures (VFxs) are the most common fractures in osteoporosis and are associated with increased morbidity, mortality, and costs. A subset of VFxs manifest clinically, usually with a sudden onset of severe back pain. Romosozumab is a monoclonal antibody that binds and...
Main Authors: | Piet Geusens, Mary Oates, Akimitsu Miyauchi, Jonathan D Adachi, Marise Lazaretti‐Castro, Peter R Ebeling, Carlos Augusto Perez Niño, Cassandra E Milmont, Andreas Grauer, Cesar Libanati |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-10-01
|
Series: | JBMR Plus |
Subjects: | |
Online Access: | https://doi.org/10.1002/jbm4.10211 |
Similar Items
-
Review of Current Real-World Experience with Teriparatide as Treatment of Osteoporosis in Different Patient Groups
by: Barbara Hauser, et al.
Published: (2021-04-01) -
Glucocorticoid-Induced Osteoporosis: The Potential Role of Romosozumab
by: Jacqueline So, et al.
Published: (2020-12-01) -
Vertebral Fracture in Postmenopausal Women with and without Osteoporosis
by: Merih Özgen, et al.
Published: (2017-08-01) -
The Impact of Vertebral Fractures on Quality of Life in Postmenopausal Osteoporosis
by: Hakan Nur, et al.
Published: (2011-12-01) -
Update on Denosumab Treatment in Postmenopausal Women with Osteoporosis
by: Yong-Ki Min
Published: (2015-03-01)